Deciphera Pharmaceuticals, Inc. to Present at the Truist Securities Life Sciences Summit

Deciphera Pharmaceuticals, Inc. to Present at the Truist Securities Life Sciences Summit




Deciphera Pharmaceuticals, Inc. to Present at the Truist Securities Life Sciences Summit

WALTHAM, Mass.–(BUSINESS WIRE)–Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that Steve Hoerter, President and Chief Executive Officer, will participate in a fireside chat at the Truist Securities Life Sciences Summit on May 5, 2021 at 9:40 AM ET. The conference will be held in a virtual meeting format.

A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investors.deciphera.com/news-events/events-presentations. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.

About Deciphera Pharmaceuticals

Deciphera is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from our platform in clinical studies, QINLOCK® is Deciphera’s FDA-approved switch-control kinase inhibitor for the treatment of fourth-line gastrointestinal stromal tumors. For more information, visit https://www.deciphera.com/ or follow us on LinkedIn and Twitter (@Deciphera).

Contacts

Investor Relations:
Jen Robinson

Deciphera Pharmaceuticals, Inc.

jrobinson@deciphera.com
781-906-1112

Media:
David Rosen

Argot Partners

David.Rosen@argotpartners.com
212-600-1902